Only ‘a few million’ Johnson & Johnson doses will be ready when the vaccine is likely to be authorized, the White House says.
A prominent White House adviser said Johnson & Johnson, whose Kovid-19 vaccine is to be authorized by the union for emergency use by the first week in March, would have only “a few million” doses.
Although the vaccine will be the third to be authorized in the United States, the country’s vaccine stock will not increase immediately. This is disappointing news for health officials and residents around the country, who were hoping that another supplier would add 13.5 million doses a week, which is now being distributed to the states by Pfizer-Bayonet and Moderna, two vaccines. Now federally authorized.
still, President Biden said On Tuesday evening, every American seeking a Kovid-19 vaccination will be able to get one by the end of July, providing a more encouraging forecast than that. Given a week ago When he warned that logistics and distribution bottlenecks beyond the end of summer would delay vaccination. Mr Biden, who made the remarks in Milwaukee during a town-hall-style meeting hosted by CNN, called the comment a bit worthy, saying that by then the dose would be “available”. But he also said that he did not expect that it would take months to get shot in people’s arms.
Johnson & Johnson’s vaccine has many advantages over Pfizer’s Modern and Modern. It is only one dose instead of two and may remain viable in a refrigerator for three months, while the other two have to be kept frozen.
But despite the federal government’s plan to shorten the timetable for vaccine development to help companies make vaccines, when they tested them in clinical trials, Johnson & Johnson still had its plant in Baltimore, MD Is struggling to increase production.
White House chief epidemiologist, Jeffrey D. Jitters, Johnson & Johnson began their work under the Trump administration. Under its contract, it is scheduled to deliver 100 million doses by the end of June – with 37 million by the end of March.
Its distribution will be “more back-end loaded”, Mr. Zients said. “We are doing everything we can to expedite the delivery schedule.”